Non-Hodgkin\'s Lymphoma News

Idiotype Vaccine Improves Disease-free Survival in Patients with Follicular Lymphoma (June 8, 2009)

Idiotype Vaccine Improves Disease-free Survival in Patients with Follicular Lymphoma BiovaxID, an individualized tumor-specific protein vaccine, prolongs disease-free survival in patients with advanced follicular lymphoma who experience complete remission... Continue Reading

Maintenance Rituxan® Prolongs Survival in Advanced Indolent Lymphoma (March 31, 2009)

Maintenance Rituxan® (rituximab) given after standard chemotherapy significantly prolongs progression-free survival (PFS) in patients with advanced-stage indolent non-Hodgkin’s lymphoma, according to the results of a study published in the Journal... Continue Reading

Smoking and Heavy Alcohol Consumption Reduce Survival in Non-Hodgkin’s Lymphoma (March 8, 2009)

Smoking and Heavy Alcohol Consumption Reduce Survival in Non-Hodgkin’s Lymphoma Patients diagnosed with non-Hodgkin’s lymphoma (NHL) who smoke tobacco products and/or drink large quantities of alcohol have a reduced chance of optimal survival.... Continue Reading

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma (March 8, 2009)

Statins May Reduce Effectiveness of Rituxan® in Non-Hodgkin’s Lymphoma Statins may reduce the effectiveness of Rituxan® (rituximab) in treatment of non-Hodgkin’s lymphoma (NHL), according to a recently published article in PLoS Med (the... Continue Reading

Tobacco and Alcohol May Decrease Survival for Non-Hodgkin’s Lymphoma Patients (March 8, 2009)

Tobacco and Alcohol May Decrease Survival for Non-Hodgkin’s Lymphoma Patients Heavy tobacco smoking and alcohol consumption may be associated with poor survival among patients with Non-Hodgkin’s Lymphoma (NHL). These findings were recently... Continue Reading

Non-Hodgkin’s Lymphoma Survivors May Suffer Symptoms of Post Traumatic Stress (March 8, 2009)

Non-Hodgkin’s Lymphoma Survivors May Suffer Symptoms of Post Traumatic Stress Patients who have been diagnosed and treated for non-Hodgkin’s lymphoma may have symptoms of post traumatic stress disorder (PTSD). These finding were recently published... Continue Reading

Treanda® plus Rituxan® Effective for Recurrent Non-Hodgkin’s Lymphoma (March 8, 2009)

Treanda® plus Rituxan® Effective for Recurrent Non-Hodgkin’s Lymphoma The treatment combination consisting of Treanda® (bendamustine) plus Rituxan® (rituximab) provides effective therapy for patients with non-Hodgkin’s lymphoma (NHL) that... Continue Reading

Treanda® Less Toxic than CHOP Chemotherapy for Non-Hodgkin’s Lymphoma (March 8, 2009)

Treanda® Less Toxic than CHOP Chemotherapy for Non-Hodgkin’s Lymphoma According to the results of a study presented at the 50th annual meeting of the American Society of Hematology, initial treatment of non-Hodgkin’s lymphoma with Treanda®... Continue Reading

BiovaxID® Improves Disease-free Survival in Non-Hodgkin’s Lymphoma (March 8, 2009)

BiovaxID® Improves Disease-free Survival in Non-Hodgkin’s Lymphoma The personalized investigative vaccine BiovaxID® (personalized anti-idiotype vaccine) significantly improves cancer-free survival among patients with non-Hodgkin’s lymphoma.... Continue Reading

Worse Prognosis for “Bulky” Disease Diffuse Large B-Cell Lymphoma (March 8, 2009)

Worse Prognosis for “Bulky” Disease Diffuse Large B-Cell Lymphoma Young patients with diffuse large-B-cell lymphoma (DLBCL) with cancerous masses that are 10.0 centimeters or greater in diameter are considered to have “bulky” disease... Continue Reading